PURPOSE: In Chile, diabetes and breast cancer are important public health problems. The association between insulin resistance and breast cancer, however, remains largely unexplored. METHODS: We conducted a case-control study to assess the relationship of insulin resistance (IR) and breast cancer in Chilean premenopausal and postmenopausal women. We compared 170 women, 33 to 86 years old, with incident breast cancer and 170 normal mammography controls, matched by 5-year age interval. Plasmatic insulin and glucose were measured and IR was calculated by the homeostasis model assessment method. Anthropometric measurements and sociodemographic and behavioral data were also collected. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by multivariable conditional logistic regression. RESULTS: IR was independently associated with breast cancer in postmenopausal women (OR = 2.70, 95%CI = 1.10-6.63), but not in premenopausal women (OR = 0.84, 95%CI = 0.20-3.52). Obesity was not associated with breast cancer at any age (OR = 0.68, 95%CI = 0.39-1.20). CONCLUSION: In this sample, IR increased the risk of breast cancer among postmenopausal women.
PURPOSE: In Chile, diabetes and breast cancer are important public health problems. The association between insulin resistance and breast cancer, however, remains largely unexplored. METHODS: We conducted a case-control study to assess the relationship of insulin resistance (IR) and breast cancer in Chilean premenopausal and postmenopausal women. We compared 170 women, 33 to 86 years old, with incident breast cancer and 170 normal mammography controls, matched by 5-year age interval. Plasmatic insulin and glucose were measured and IR was calculated by the homeostasis model assessment method. Anthropometric measurements and sociodemographic and behavioral data were also collected. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by multivariable conditional logistic regression. RESULTS: IR was independently associated with breast cancer in postmenopausal women (OR = 2.70, 95%CI = 1.10-6.63), but not in premenopausal women (OR = 0.84, 95%CI = 0.20-3.52). Obesity was not associated with breast cancer at any age (OR = 0.68, 95%CI = 0.39-1.20). CONCLUSION: In this sample, IR increased the risk of breast cancer among postmenopausal women.
Authors: Gillian Libby; Louise A Donnelly; Peter T Donnan; Dario R Alessi; Andrew D Morris; Josie M M Evans Journal: Diabetes Care Date: 2009-06-29 Impact factor: 19.112
Authors: P Boyle; M Boniol; A Koechlin; C Robertson; F Valentini; K Coppens; L-L Fairley; M Boniol; T Zheng; Y Zhang; M Pasterk; M Smans; M P Curado; P Mullie; S Gandini; M Bota; G B Bolli; J Rosenstock; P Autier Journal: Br J Cancer Date: 2012-09-20 Impact factor: 7.640
Authors: Jakob Starup-Linde; Oystein Karlstad; Stine Aistrup Eriksen; Peter Vestergaard; Heleen K Bronsveld; Frank de Vries; Morten Andersen; Anssi Auvinen; Jari Haukka; Vidar Hjellvik; Marloes T Bazelier; Anthonius de Boer; Kari Furu; Marie L De Bruin Journal: Curr Drug Saf Date: 2013-11
Authors: Raúl M Luque; Laura M López-Sánchez; Alicia Villa-Osaba; Isabel M Luque; Ana L Santos-Romero; Elena M Yubero-Serrano; María Cara-García; Marina Álvarez-Benito; José López-Mirand A; Manuel D Gahete; Justo P Castaño Journal: Oncotarget Date: 2017-08-23